Free Webinar: Monoclonal Antibodies – Response to the COVID-19 Outbreak
You are invited to join AFMC for a complimentary educational webinar on Friday, Feb. 5 from 12:30 - 1:30 p.m.
AFMC’s Chief Medical Officer and AMS President, Dr. Chad Rodgers and Dr. Atul Kothari, Senior Physician Specialist with the Arkansas Department of Health will discuss and share information on Monoclonal Antibodies – Response to the COVID-19 Outbreak.
Monoclonal antibodies are laboratory-made proteins that mimic your immune system’s ability to fight off COVID-19. The FDA issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibodies for the treatment of mild to moderate symptoms of COVID-19 in adults and pediatric patients.
- Who is eligible for the monoclonal antibody therapy?
- Benefits of antibody therapy
- Where can patients receive treatment?
In response to the COVID-19 outbreak in Arkansas, the Division of Medical Services (DMS) is now covering administration of monoclonal antibodies.